Home › Funds › Blue Owl Capital Holdings LP › ADCT

Blue Owl Capital Holdings LP position in ADCT

ADC THERAPEUTICS SA · Health Care

Blue Owl Capital Holdings LP reported holding 733,568 shares of ADCT (ADC THERAPEUTICS SA) in its Q3 2026 13F filing — a position valued at US$895K, representing 0.17% of its reported portfolio and ranking #34 among its reported holdings. Blue Owl Capital Holdings LP has disclosed ADCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)733.57K sh
Reported value held$894.95K
Portfolio Weight0.17%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's ADCT position evolved

Blue Owl Capital Holdings LP first disclosed a stake in ADCT in Q3 2023 at 733,568 shares (US$654K). The position peaked in Q1 2024 at 733,568 shares, worth US$3.3M. Across 13 filings, Blue Owl Capital Holdings LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 733,568 shares valued at US$895K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 733.57K $654.49K New
Q4 2023 733.57K $1.22M Hold
Q1 2024 733.57K $3.29M Hold
Q2 2024 733.57K $2.32M Hold
Q3 2024 733.57K $2.31M Hold
Q4 2024 733.57K $1.46M Hold
Q1 2025 733.57K $1.03M Hold
Q2 2025 733.57K $1.97M Hold
Q3 2025 733.57K $2.93M Hold
Q4 2025 733.57K $2.93M Hold
Q1 2026 733.57K $2.59M Hold
Q2 2026 733.57K $784.92K Hold
Q3 2026 733.57K $894.95K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ADCT and 13F data

ADCT (ADC THERAPEUTICS SA) is a Health Care company. 28 other funds we track also report a position in ADCT — the largest reported positions include Redmile Group, LLC (US$12.3M), TCG Crossover Management, LLC (US$12.2M), Prosight Management, LP (US$8.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ADCT

All ADCT fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held ADCT?

Blue Owl Capital Holdings LP has disclosed ADCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Blue Owl Capital Holdings LP's current position in ADCT?

As of Q3 2026, Blue Owl Capital Holdings LP holds 733.57K shares of ADCT (ADC THERAPEUTICS SA), valued at $894.95K, representing 0.17% of its reported portfolio and ranking #34.

Has Blue Owl Capital Holdings LP been buying or selling ADCT?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP held unchanged its position in ADCT. The position peaked in Q1 2024 at 733.57K shares.

Which other funds hold ADCT?

Other major institutional holders of ADCT include Redmile Group, LLC, TCG Crossover Management, LLC, Prosight Management, LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.